Zepbound

Zepbound

Managing weight is one of the most challenging health journeys a person can undertake. For those who have struggled with diet and exercise alone, a new class of weight management medications is changing the conversation. Zepbound is one of the most talked-about options in this space — and for good reason.

This guide covers everything you need to know about Zepbound: what it is, how it works, its benefits, dosage, and potential side effects.

What Is Zepbound?

Zepbound is a prescription injectable weight management medication containing the active ingredient tirzepatide. It was approved by the U.S. Food and Drug Administration (FDA) in November 2023 for chronic weight management in adults with obesity or overweight with at least one weight-related health condition. Developed by Eli Lilly, Zepbound represents a significant advancement in the pharmacological approach to obesity treatment.

Unlike older weight loss drugs, Zepbound targets two separate hormone receptors in the body, making it a dual-action therapy. It is administered once weekly as a subcutaneous injection and is intended for use alongside a reduced-calorie diet and increased physical activity.

How Zepbound Works

Zepbound works by mimicking two naturally occurring gut hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones play a key role in regulating blood sugar, appetite, and how the body processes food.

By activating both GLP-1 and GIP receptors simultaneously, tirzepatide — the active compound in Zepbound — signals to the brain that the body is full, slows gastric emptying, and reduces overall food intake. This dual mechanism is what sets Zepbound apart from single-receptor medications like semaglutide (Wegovy or Ozempic).

The result is a more powerful appetite-suppressing effect, which supports greater and more sustained weight loss compared to earlier-generation medications